BNP Paribas Financial Markets’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-94
| Closed | -$470 | – | 3503 |
|
|
2024
Q1 | $470 | Sell |
94
-3
| -3% | -$15 | ﹤0.01% | 3230 |
|
|
2023
Q4 | $652 | Hold |
97
| – | – | ﹤0.01% | 3162 |
|
|
2023
Q3 | $892 | Sell |
97
-3,005
| -97% | -$27.6K | ﹤0.01% | 3069 |
|
|
2023
Q2 | $65.5K | Buy |
3,102
+912
| +42% | +$19.3K | ﹤0.01% | 2773 |
|
|
2023
Q1 | $58.9K | Buy |
2,190
+1,959
| +848% | +$52.7K | ﹤0.01% | 2781 |
|
|
2022
Q4 | $8.17K | Sell |
231
-201
| -47% | -$7.11K | ﹤0.01% | 2966 |
|
|
2022
Q3 | $97.5K | Buy |
432
+122
| +39% | +$27.5K | ﹤0.01% | 3079 |
|
|
2022
Q2 | $58.6K | Buy |
310
+209
| +207% | +$39.5K | ﹤0.01% | 2884 |
|
|
2022
Q1 | $25K | Sell |
101
-443
| -81% | -$110K | ﹤0.01% | 3120 |
|
|
2021
Q4 | $84.7K | Buy |
544
+317
| +140% | +$49.4K | ﹤0.01% | 3003 |
|
|
2021
Q3 | $45.5K | Buy |
227
+104
| +85% | +$20.9K | ﹤0.01% | 2940 |
|
|
2021
Q2 | $31.5K | Sell |
123
-16
| -12% | -$4.09K | ﹤0.01% | 2818 |
|
|
2021
Q1 | $37K | Sell |
139
-71
| -34% | -$18.9K | ﹤0.01% | 3111 |
|
|
2020
Q4 | $77.5K | Sell |
210
-10
| -5% | -$3.69K | ﹤0.01% | 2692 |
|
|
2020
Q3 | $53.8K | Buy |
220
+178
| +424% | +$43.5K | ﹤0.01% | 2814 |
|
|
2020
Q2 | $12K | Sell |
42
-198
| -83% | -$56.3K | ﹤0.01% | 3000 |
|
|
2020
Q1 | $49K | Buy |
240
+150
| +167% | +$30.7K | ﹤0.01% | 2936 |
|
|
2019
Q4 | $40.2K | Sell |
90
-9
| -9% | -$4.02K | ﹤0.01% | 3092 |
|
|
2019
Q3 | $30.3K | Buy |
+99
| New | +$30.3K | ﹤0.01% | 3115 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$621 | – | 3793 |
|
|
2018
Q1 | $621 | Hold |
2
| – | – | ﹤0.01% | 3521 |
|
|
2017
Q4 | $879 | Hold |
2
| – | – | ﹤0.01% | 3420 |
|
|
2017
Q3 | $693 | Hold |
2
| – | – | ﹤0.01% | 3461 |
|
|
2017
Q2 | $498 | Buy |
+2
| New | +$498 | ﹤0.01% | 3502 |
|
|
2017
Q1 | – | Sell |
-2
| Closed | -$664 | – | 3402 |
|
|
2016
Q4 | $664 | Sell |
2
-7
| -78% | -$2.32K | ﹤0.01% | 3372 |
|
|
2016
Q3 | $3.78K | Buy |
9
+4
| +80% | +$1.68K | ﹤0.01% | 3423 |
|
|
2016
Q2 | $2.72K | Buy |
+5
| New | +$2.72K | ﹤0.01% | 3427 |
|